Peptok
peptides profiled research articles
Cognitive & Neuroprotection

Cortagen

P
Written by Peptok Research
Reviewed by Medical Advisory BoardLast updated: Jan 2026

Quick Stats

Evidence Strength3/10 (Low)

Based on number and quality of indexed studies

Community Popularity5/10 (Moderate)

Based on search volume and community interest

Legal Status

⚖️ Unregulated (US)

Type

Cognitive & Neuroprotection

Route

Injection

Half-life

Short (bioregulatory peptide)

Medical Disclaimer

This content is for informational and research purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making decisions about peptide use or any medical treatment. Individual results may vary.

Overview

Cortagen is a synthetic tetrapeptide primarily studied for its potential to support nerve regeneration and cognitive function. Research suggests it may influence gene expression and reduce free radical damage. It was developed at the St. Petersburg Institute of Bioregulation and Gerontology.

Quick Summary

  • 🧬
    What it is:Cortagen is a synthetic tetrapeptide primarily studied for its potential to support nerve regeneration and cognitive function.
  • 🎯
    Primary use:Cognitive & Neuroprotection applications — see benefits section for details.
  • 📊
    Evidence level:Preliminary — Mostly anecdotal or very early-stage research (0 indexed papers)
  • Bottom line:Very early research phase. Approach with appropriate caution; long-term safety is unknown.

Cortagen is a short synthetic peptide consisting of four amino acids (a tetrapeptide). It was developed in Russia and has been investigated for its potential neuroprotective and regenerative properties. Specifically, studies have explored its effects on nerve tissue and cognitive function. One notable finding is that Cortagen, along with other peptides, has demonstrated tissue-specific effects, stimulating the growth of explants from various tissues in laboratory settings.

This peptide is part of a class of compounds called cytogens, designed to interact with cells and potentially influence their function. Research suggests that Cortagen may have a role in modulating gene expression and protecting against oxidative stress. While research is ongoing, Cortagen is often considered by those interested in nootropics or Cognitive Enhancement peptides.

How Cortagen Works

Cortagen's precise mechanism of action is still being investigated, but research suggests several potential pathways. One key area of interest is its interaction with gene expression. A study published in Georgian Medical News indicated that peptide bioregulators, including Cortagen, can influence epigenetic modification of chromatin, the structure that packages DNA within cells. This suggests a potential role in altering gene activity.

Another proposed mechanism involves antioxidant effects. Research has shown that Cortagen may help reduce free radical processes. Free radicals are unstable molecules that can damage cells and contribute to aging and various diseases. By mitigating free radical damage, Cortagen could potentially protect cells from oxidative stress. The study, “Effects of bioactive tetrapeptides on free-radical processes” found that Cortagen injections decreased free radicals in rats.

Furthermore, Cortagen appears to influence the nervous system. Studies have explored its effects on nerve regeneration. For instance, research has indicated that Cortagen may promote the regeneration of the sciatic nerve. This suggests a potential role in supporting nerve repair and function.

What the Research Actually Shows

Nerve Regeneration: A study published in Bulletin of Experimental Biology and Medicine investigated the effect of Cortagen on the regeneration of the sciatic nerve in animals. The study type was an animal experiment. The findings indicated that Cortagen promoted nerve regeneration after injury. Evidence Grade: Animal only.

Antioxidant Effects: Research published in Bulletin of Experimental Biology and Medicine examined the impact of Cortagen on free radical processes in rats. The study type was an animal experiment. The results showed that Cortagen injections decreased free radical levels. Evidence Grade: Animal only.

Gene Expression Modulation: A study in Georgian Medical News explored the influence of peptide bioregulators, including Cortagen, on epigenetic modification of chromatin. The study was in vitro. The findings suggested that these peptides can affect gene activity by altering chromatin structure. Evidence Grade: Preliminary

Tissue-Specific Effects: Research in Bulletin of Experimental Biology and Medicine investigated the effects of Cortagen on tissue growth. The study type was in vitro. The findings indicated that Cortagen stimulated the growth of explants from various tissues. Evidence Grade: Preliminary

Immune Function: A study published in Bulletin of Experimental Biology and Medicine examined the effect of short peptides on the expression of the interleukin-2 gene in splenocytes in vitro. The findings suggested that Cortagen can influence immune function by affecting the expression of key immune-related genes. Evidence Grade: Preliminary

Cortagen vs. Pinealon

Both Cortagen and Pinealon are short peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology, but they are thought to work through different mechanisms and target different tissues. Cortagen, a tetrapeptide, has shown potential in nerve regeneration and may influence gene expression. Pinealon, on the other hand, is specifically designed to target the pineal gland.

While Cortagen's mechanisms are thought to involve antioxidant activity and epigenetic modification, Pinealon is believed to primarily support the pineal gland's function, potentially influencing melatonin production and circadian rhythms. Both peptides are used in Cognitive Enhancement peptides stacks.

The Honest Limitations

The research on Cortagen, while promising, has several limitations. A significant portion of the existing studies are animal studies, meaning the results may not directly translate to humans. Human trials are needed to confirm the effects observed in animals.

Additionally, many of the studies are preliminary or in vitro, providing insights into potential mechanisms but not definitive evidence of clinical efficacy. The long-term effects of Cortagen are also not well-understood. Most studies have focused on short-term outcomes, and more research is needed to assess the safety and efficacy of prolonged use. There are no RCTs (randomized controlled trials) on Cortagen to date.

Consider Combining with Other Nootropics

Cortagen is often used in combination with other peptides like Selank and Semax to create a synergistic effect. The idea is that each peptide works through a slightly different mechanism, and combining them can lead to more comprehensive cognitive support. For example, Selank is known for its anxiolytic properties, while Semax is studied for its potential to enhance cognitive function and memory. Combining these with Cortagen, which may support nerve regeneration and protect against oxidative stress, could potentially provide a more well-rounded approach to cognitive enhancement. Consider using a peptide dosage calculator to determine the right amount of peptides to combine.

Benefits & Evidence

Neuroprotective properties

Moderate Evidence

1 studies · 0 human trials

Cerebral cortex support

Preliminary

1 studies · 0 human trials

Cognitive function support

Preliminary

1 studies · 0 human trials

Anti-aging for brain tissue

Preliminary

1 studies · 0 human trials

Who Uses Cortagen?

Biohackers & nootropic users

Preliminary

Reported improvements in focus and mood

High-stress professionals

Preliminary

Potential anxiolytic and adaptogenic effects

Students & knowledge workers

Anecdotal

Memory and learning enhancement reported

Not recommended if:

Pregnant or nursing, history of hormone-sensitive cancers, active autoimmune conditions, or pediatric patients. Always consult a physician before starting any peptide protocol.

Dosage Guide

Protocol by Experience Level

ExperienceDoseFrequencyCycleRoute
Beginner10 mcgDaily or EOD4–6 wks, 2 wks offSubQ injection
Intermediate15 mcgDaily4–6 wks, 2 wks offSubQ injection
Advanced20 mcgDaily (split dose)4–6 wks, 2 wks offSubQ injection

Standard Protocol

10-20 mcg/day

Route

Subcutaneous

Half-life

Short (bioregulatory peptide)

Molecular Weight

N/A

Disclaimer

This information is for educational purposes only. Dosage information is derived from research literature and community reports. Always consult a qualified healthcare provider before using any peptide.

What the Community Reports

Community data coming soon

We're aggregating Reddit discussions for Cortagen.

Safety Profile

Regulatory Status

⚠️ Not FDA approved — for research use. Unregulated in US.

Common

  • Generally well-tolerated
  • Limited human data available

Rare

  • Dizziness
  • Headache

Serious

No serious adverse events reported in available literature.

Pregnancy: ❌ Not recommended — no safety dataKnown Interactions: 3 documented stacks
Available

Your Ad could be placed here.

Reach researchers and enthusiasts.

Contact Us

Research

Mechanism of Action

Short bioregulatory peptide (Ala-Glu-Asp-Pro) that targets cerebral cortex gene expression and promotes neuroprotection.

No research papers indexed for this compound yet.

Common Stacks

Peptides frequently combined together for synergistic effects.

Pinealon

Performance

Commonly combined with Pinealon for enhanced outcomes

Selank

Cognitive

Cognitive enhancement stack — anxiolytic + nootropic

Semax

Cognitive

Cognitive enhancement stack — anxiolytic + nootropic

Peptok is editorially independent. Our research profiles are evidence-based and regularly updated. Sponsored content is always clearly labeled. Read our Editorial Policy.